[HTML][HTML] Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer
…, H Bandos, E Senkus, JM Suga… - … England Journal of …, 2021 - Mass Medical Soc
Background Poly(adenosine diphosphate–ribose) polymerase inhibitors target cancers with
defects in homologous recombination repair by synthetic lethality. New therapies are …
defects in homologous recombination repair by synthetic lethality. New therapies are …
[HTML][HTML] Functional near-infrared spectroscopy and its clinical application in the field of neuroscience: advances and future directions
WL Chen, J Wagner, N Heugel, J Sugar… - Frontiers in …, 2020 - frontiersin.org
Similar to functional magnetic resonance imaging (fMRI), functional near-infrared spectroscopy
(fNIRS) detects the changes of hemoglobin species inside the brain, but via differences …
(fNIRS) detects the changes of hemoglobin species inside the brain, but via differences …
Adjuvant palbociclib for early breast cancer: the PALLAS trial results (ABCSG-42/AFT-05/BIG-14-03)
…, G Pfeiler, KD Miller, M Colleoni, JM Suga… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE Palbociclib is a cyclin-dependent kinase 4 and 6 inhibitor approved for advanced
breast cancer. In the adjuvant setting, the potential value of adding palbociclib to endocrine …
breast cancer. In the adjuvant setting, the potential value of adding palbociclib to endocrine …
[HTML][HTML] Nivolumab is effective in mismatch repair–deficient noncolorectal cancers: Results from arm Z1D—A subprotocol of the NCI-MATCH (EAY131) study
…, SR Hamilton, N Bahary, JM Suga… - Journal of Clinical …, 2020 - ncbi.nlm.nih.gov
PURPOSE The National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH)
trial, the largest national precision oncology study to date (> 1,100 sites) of patients with …
trial, the largest national precision oncology study to date (> 1,100 sites) of patients with …
Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin.
…, H Masuzaki, K Hosoda, M Aizawa-Abe, J Suga… - Diabetes, 1999 - Am Diabetes Assoc
Excess of body fat, or obesity, is a major health problem and confers a higher risk of cardiovascular
and metabolic disorders such as diabetes, hypertension, and coronary heart disease…
and metabolic disorders such as diabetes, hypertension, and coronary heart disease…
Haematogenous metastastic patterns in colonic carcinoma: an analysis of 1541 necropsies
…, MJ Lopez, RI Shaw‐Dunn, J Sugar… - The Journal of …, 1986 - Wiley Online Library
The sequence of events in haematogenous metastasis from colonic carcinoma was analysed,
using 1541 necropsy reports from 16 centres. The findings are consistent with the cascade …
using 1541 necropsy reports from 16 centres. The findings are consistent with the cascade …
Assessment of treatment with sorafenib plus doxorubicin vs sorafenib alone in patients with advanced hepatocellular carcinoma: phase 3 CALGB 80802 randomized …
…, J Balletti, AB El-Khoueiry, JJ Harding, JM Suga… - JAMA …, 2019 - jamanetwork.com
Importance Previous communication has reported significant improvement in overall survival
(OS) when using doxorubicin plus sorafenib in the treatment of advanced hepatocellular …
(OS) when using doxorubicin plus sorafenib in the treatment of advanced hepatocellular …
La-and Mn-doped cobalt spinel oxygen evolution catalyst for proton exchange membrane electrolysis
Discovery of earth-abundant electrocatalysts to replace iridium for the oxygen evolution
reaction (OER) in a proton exchange membrane water electrolyzer (PEMWE) represents a …
reaction (OER) in a proton exchange membrane water electrolyzer (PEMWE) represents a …
[HTML][HTML] TP53 gain-of-function and non–gain-of-function mutations are differentially associated with sidedness-dependent prognosis in metastatic colorectal cancer
…, A Arora, T Sundaresan, JM Suga… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
PURPOSE To examine the association of gain-of-function (GOF) and non–gain-of-function (non-GOF)
TP53 mutations with prognosis of metastatic right-sided (RCC) versus left-sided …
TP53 mutations with prognosis of metastatic right-sided (RCC) versus left-sided …
S1417CD: a prospective multicenter cooperative group-led study of financial hardship in metastatic colorectal cancer patients
…, JM Unger, AK Darke, JM Suga… - JNCI: Journal of the …, 2022 - academic.oup.com
Background Financial toxicity is a growing problem in oncology, but no prior studies have
prospectively measured the financial impact of cancer treatment in a diverse national cohort of …
prospectively measured the financial impact of cancer treatment in a diverse national cohort of …